fb-pixel Skip to main content

Biogen cutting 104 jobs in Cambridge

Scientist Timothy Sullivan working in a Biogen lab last year. Suzanne Kreiter/Globe staff.File 2015

More than 100 Biogen Inc. employees are losing their jobs as the Cambridge biotech company moves forward with an earlier announced plan to end drug manufacturing operations in Massachusetts.

In June, the company said it planned to close a 66,000-square-foot production plant — Biogen’s oldest and smallest manufacturing site — on its campus in Cambridge’s Kendall Square by the end of the year unless it found another tenant. As of mid-year, about 285 people worked there.

Biogen confirmed Wednesday that the plant’s operation had been transferred to Lexington-based Brammer Bio, a company Biogen may be working with on gene therapy programs. But the new operator needs fewer workers. As a result Biogen will lay off 104 employees who work there, as well as some at a Somerville warehouse the company also is closing.


Robert Weisman can be reached at robert.weisman@globe.com. Follow him on Twitter @GlobeRobW.